Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

Jennifer G. Robinson, Michel Farnier, Michel Krempf, Jean Bergeron, Gérald Luc, Maurizio Rocco Averna, Erik S.G. Stroes, Gisle Langslet, Frederick Johan Raal, Mahfouz El Shahawy, Michael J. Koren, Norman E. Lepor, Christelle Lorenzato, Robert C. Pordy, Umesh Chaudhari, John J.P. Kastelein

View at source ↗PDF ↗Article2,295 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1056/nejmoa1501031
Published
Mar 15, 2015
Venue
New England Journal of Medicine
DOI
10.1056/nejmoa1501031
PubMed
25773378
Categories
Lipoproteins and Cardiovascular Health
Provenance
openalex

Topics